Dr. Henderson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S Maryland Ave
Chicago, IL 60637Phone+1 888-824-0200Fax+1 773-702-9881
Education & Training
- Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2002 - 2005
- Johns Hopkins UniversityResidency, Pediatrics, 1999 - 2002
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1999
Certifications & Licensure
- IL State Medical License 2005 - 2026
- MA State Medical License 2002 - 2007
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies Start of enrollment: 2008 Jul 17
- Childhood Cancer Survivor Study Start of enrollment: 1995 Jan 05
- Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors Start of enrollment: 2010 Sep 01
Publications & Presentations
PubMed
- 145 citationsSecondary Sarcomas in Childhood Cancer Survivors: A Report From the Childhood Cancer Survivor StudyTara O. Henderson, John Whitton, Marilyn Stovall, Ann C. Mertens, Pauline Mitby
Journal of the National Cancer Institute. 2007-02-21 - 44 citationsSuppression of bone density loss and bone turnover in patients with hormone-sensitive prostate cancer and receiving zoledronic acidChristopher W. Ryan, Dezheng Huo, Kathryn A. Bylow, Laurence M. Demers, Walter M. Stadler
BJU International. 2007-07-01 - 155 citationsLate mortality and chronic health conditions in long-term survivors of early-adolescent and young adult cancers: a retrospective cohort analysis from the Childhood Can...Eugene Suh, Kayla Stratton, Wendy M. Leisenring, Paul C. Nathan, Jennifer S. Ford
The Lancet. Oncology. 2020-02-14
Abstracts/Posters
- Low-Dose Tamoxifen (LDTam) As a Breast Cancer (BC) Risk-Reduction Strategy in Lymphoma Survivors Exposed to Chest Radiation Therapy (RT) during Adolescence/Young Adult...Tara O. Henderson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- Pediatric Clinical Malignant Hematology61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Transitions From the Pediatric Perspective60th American Society of Hematology Annual Meeting - 11/30/2018
- Living Well Beyond Cancer: #AYAsurvivorship2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
Press Mentions
- UChicago Medical Students Publish First-Author ResearchSeptember 3rd, 2024
- Association of Changes in Cancer Therapy over 3 Decades with Risk of Subsequent Breast Cancer Among Female Childhood Cancer SurvivorsOctober 13th, 2022
- Risk of Secondary Breast Cancer After Childhood Cancer Is Declining, Study SuggestsOctober 13th, 2022
- Join now to see all
Grant Support
- Health Beliefs And Behavior: Cohort Studies In Pediatric Cancer SurvivorshipNational Cancer Institute2008–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: